Halpern, Wendy G <br/><br/>
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.  [electronic resource] 

 -  Toxicologic pathology  08 2016 
 - 789-809 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1533-1601 
<br/><br/><label>Standard No.: </label>10.1177/0192623316650052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Drug Evaluation, Preclinical--methods<br/>Guideline Adherence<br/>Humans<br/>Pathology, Clinical--methods<br/>Toxicity Tests--methods<br/>Toxicology--methods